ARTL

Artelo Biosciences, Inc. (ARTL) ESG Analysis Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

ARTL provides no disclosed emissions, energy, or waste metrics in the supplied data, leaving its environmental profile less transparent than peers with published sustainability reporting.

Zero reported R&D intensity may indicate limited investment in cleaner process innovation relative to peers that disclose environmental efficiency programs, constraining long-term decarbonization visibility.

The absence of capital-intensive leverage suggests a lighter physical footprint than industrial peers, but this is not enough to offset missing environmental disclosure.

Without verified environmental targets or third-party assurance, ARTL appears broadly average to weaker versus peers that can evidence measurable environmental management.

Social

Score:

No workforce, safety, turnover, or diversity metrics are provided, so ARTL’s social positioning is harder to verify than peers with fuller human-capital disclosure.

Zero stock-based compensation to revenue may imply lower equity-linked retention incentives than peers, which can weaken alignment and talent retention visibility.

The limited disclosed operating intensity reduces some labor and community exposure versus asset-heavy peers, but it also leaves social risk management opaque.

Overall, ARTL appears closer to the peer median on social factors, with transparency gaps offsetting the absence of obvious structural labor or safety burdens.

Governance

Score:

Very low debt-to-equity and net debt-to-EBITDA indicate conservative balance-sheet governance versus more leveraged peers, reducing creditor pressure and refinancing risk.

Zero stock-based compensation to revenue suggests less dilution pressure than peers with heavier equity awards, although it may also reflect limited disclosure depth.

The provided metrics do not show major leverage or capital-allocation red flags, which supports a somewhat better governance profile than indebted peers.

However, the lack of board, audit, and control disclosures prevents ARTL from ranking as a strong governance leader relative to peers with fuller transparency.

Overall Score

Score:

ARTL’s ESG positioning is broadly average versus peers, with conservative leverage supporting governance while limited environmental and social disclosure constrains a stronger relative score.

Score Driver: Conservative Leverage And Low Dilution Risk Are The Clearest Relative Strengths, But Incomplete ESG Disclosure Keeps The Overall Profile Only Moderate.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Artelo Biosciences, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →